Valneva SE logo

Valneva SE

LTS:0OB3 (France)  
€ 1.79 (-2.29%) Dec 2
At Loss
P/B:
1.38
Market Cap:
€ 289.83M ($ 304.59M)
Enterprise V:
€ 334.74M ($ 351.79M)
Volume:
59.49K
Avg Vol (2M):
25.37K
Trade In:
Volume:
59.49K
At Loss
Avg Vol (2M):
25.37K

Business Description

Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
Name Current Vs Industry Vs History
Cash-To-Debt 0.78
Equity-to-Asset 0.42
Debt-to-Equity 0.93
Debt-to-EBITDA 9.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.07
Distress
Grey
Safe
Beneish M-Score -2.77
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 11.56
9-Day RSI 16.81
14-Day RSI 21.46
6-1 Month Momentum % -34.85
12-1 Month Momentum % -48.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.78
Quick Ratio 2.25
Cash Ratio 1.43
Days Inventory 178.24
Days Sales Outstanding 80.19
Days Payable 147.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.2
Shareholder Yield % -15.23

Financials (Next Earnings Date:2025-03-20)

LTS:0OB3's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Valneva SE Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 158.535
EPS (TTM) (€) -0.06
Beta 0.88
Volatility % 53.39
14-Day RSI 21.46
14-Day ATR (€) 0.112725
20-Day SMA (€) 2.170625
12-1 Month Momentum % -48.67
52-Week Range (€) 1.772 - 5.43
Shares Outstanding (Mil) 162.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Valneva SE Filings

Filing Date Document Date Form
No Filing Data

Valneva SE Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Valneva SE Frequently Asked Questions

What is Valneva SE(LTS:0OB3)'s stock price today?
The current price of LTS:0OB3 is €1.79. The 52 week high of LTS:0OB3 is €5.43 and 52 week low is €1.77.
When is next earnings date of Valneva SE(LTS:0OB3)?
The next earnings date of Valneva SE(LTS:0OB3) is 2025-03-20.
Does Valneva SE(LTS:0OB3) pay dividends? If so, how much?
Valneva SE(LTS:0OB3) does not pay dividend.

Press Release

Subject Date
No Press Release